Publication date: Jul 09, 2025
The company has secured more than $800 million in equity and debt financing since its founding. READ MORE IN REFRESH MIAMI: In the future, the technology could be used to treat Alzheimers and other diseases of the brain. Insightec was founded in Israel in 1999. The procedure is incisionless and does not require implanted hardware. Parkinsons Disease is expected to affect more than 1. 2 million Americans by 2030. Ferr was named Insightec CEO in 2016 and has always run the company from Miami.
| Concepts | Keywords |
|---|---|
| Ceo | Approval |
| Medtech | Based |
| Miami | Bilateral |
| Parkinsons | Company |
| Exablate | |
| Fda | |
| Ferr | |
| Insightec | |
| Miami | |
| Neuro | |
| Options | |
| Parkinsons | |
| Procedure | |
| Treat | |
| Treatment |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Nonoxynol-9 |
| disease | MESH | dyskinesia |
| disease | MESH | movement disorders |
| disease | MESH | essential tremor |
Original Article
(Visited 10 times, 1 visits today)